
FDA-Approved To Reduce Symptoms Of Depression
Spravato is the brand name for esketamine, a medication used to treat treatment-resistant depression. It is administered as a nasal spray and can be effective in reducing symptoms of depression, even in who have not responded to other forms of treatment.
Nushama offers Spravato in an exquisite, spa-like setting without the luxury cost: treatment may be covered by insurance, depending on your carrier and policy. Discovery calls are complimentary.

SPRAVATO TREATMENT LED BY
Dr. Phillip Romero
Senior Psychiatrist
*By providing your contact information you may receive texts, e-mails and phone calls from Nushama. Reply STOP to end texts at any time. No purchase is required. Nushama currently accepts Optum (United Healthcare and Oxford) and Cigna insurance.
Schedule Your Free Discovery Call
Which Location Works Best for You?
Have you tried at least two types of oral antidepressants to manage your depression?
Nushama currently accepts Aetna, Blue Cross Blue Shield, Cigna, Emblem GHI, Medicare, Humana, Oscar, Oxford, and United Healthcare. We also accept Optum (United Healthcare and Oxford) and are in the process of expanding our coverage to include additional insurance providers."
*By providing your contact information you may receive texts, e-mails and phone calls from Nushama. Reply STOP to end texts at any time. No purchase is required. Nushama currently accepts Optum (United Healthcare and Oxford) and Cigna insurance.
FDA-Approved To Reduce Symptoms Of Depression
Spravato is the brand name for esketamine, a medication used to treat treatment-resistant depression. It is administered as a nasal spray and can be effective in reducing symptoms of depression, even in Image Featurepatients who have not responded to other forms of treatment.
Nushama offers Spravato in an exquisite, spa-like setting without the luxury cost: treatment may be covered by insurance, depending on your carrier and policy. Discovery calls are complimentary.

SPRAVATO TREATMENT LED BY
Dr. Phillip Romero
Senior Psychiatrist
Spravato (Esketamine) Nasal Spray is FDA Approved for those who have been diagnosed with the following conditions:

Treatment-resistant depression

Major depressive disorder

Suicidal ideation or behaviors

Spravato (generic name esketamine), is a medication used by those with a depressive disorder who have not responded sufficiently to other forms of depression treatment. Molecularly, it is half of the molecular composition of ketamine, the s-isomer, hence the name s-ketamine or esketamine. Ketamine itself is a 60-year-old FDA-approved anesthetic. In the early 2000s, researchers began demonstrating ketamine’s rapid-acting antidepressant effects when provided intravenously in small doses.
Spravato, on the other hand, is administered as a nasal spray and must be provided with an oral antidepressant. It is self-administered but only under the direct supervision of a licensed medical professional in a clinical setting. Spravato is typically given two times per week for the first month, followed by once a week ongoingly for maintenance treatment.
Spravato (generic name esketamine), is a medication used by those with a depressive disorder who have not responded sufficiently to other forms of depression treatment. Molecularly, it is half of the molecular composition of ketamine, the s-isomer, hence the name s-ketamine or esketamine. Ketamine itself is a 60-year-old FDA-approved anesthetic. In the early 2000s, researchers began demonstrating ketamine’s rapid-acting antidepressant effects when provided intravenously in small doses.

Spravato, on the other hand, is administered as a nasal spray and must be provided with an oral antidepressant. It is self-administered but only under the direct supervision of a licensed medical professional in a clinical setting. Spravato is typically given two times per week for the first month, followed by once a week ongoingly for maintenance treatment.
Guided by a Team With Deep and Recognized Expertise in Mental Health
02
Detailed Testimonials from Our Members Covering Every Step of Your Treatment
03
Accredited, Compassionate Therapists and Coaches for Exceptional Care
05
The Leading Clinic in Ketamine Therapy
06
Flexible Payment Options
07
Free Community Events to Aid with After Care
Nushama’s senior psychiatrist, Dr Phillip Romero, and his team of advanced practitioners have specialized education and training in mental health treatments. Our philosophy is that people were not put on this planet to suffer and there are a myriad of treatment modalities available to help people navigate the human experience.
Sometimes a little medicine goes a long way. Sometimes it is important and needed. We do feel that on occasion, the additional side effects of certain medications outweigh the benefits that they provide.
Once the diagnosis has been made through careful evaluation, then it can be decided if medication is needed – and in what amounts over what period.

Phillip Romero, MD
SENIOR PSYCHIATRIST

Phillip Romero, MD
SENIOR PSYCHIATRIST
Leading Practitioner in Ketamine Therapy
Medically Trained Professionals
Decades of Experience
Evidence-Based Treatment
Beautiful and Calming Environment
Safe Yet Powerful Psychedelic Journey
Minutes from Grand Central Station
Up to Full Insurance Coverage
Enter Nushama, and an immersive, journey-like experience begins. Inspired by how an altered state of consciousness can look and feel, Alexandra Hayden of Octave Studio curates a psychedelic-inspired setting for preparation and integration therapy.
There are 18 rooms in all, each named after psychedelic legends. Jessica Lichtenstein NFTs and Navina Khatib therapeutic art invoke new beginnings and the beauty of a journey. SVAGO zero-gravity chairs and relaxation Moon Pods foster a calming, nurturing environment.
Nushama Wellness | nushamatherapy.com
Ketamine nasal spray (intranasal ketamine) is a medication that is administered through the nose. It delivers a controlled dose of ketamine, a psychedelic medicine, that can help with conditions like depression, anxiety, PTSD, addictions and other mood disorders.
Ketamine nasal spray (intranasal ketamine) works by being absorbed through the nasal mucosa, quickly entering the bloodstream. It then acts on certain receptors in the brain, leading to changes in mood and perception.
Ketamine nasal spray (intranasal ketamine) is used to treat conditions like depression, anxiety, PTSD, addictions, eating disorders and other mental health conditions. Intranasal ketamine is a promising option to many patients who may not see the results they would like from other forms of depression medication.
Ketamine nasal spray (intranasal ketamine) is safe when used under professional medical supervision and according to prescribed dosage guidelines. Self-administration or misuse of ketamine can pose significant risks and may lead to adverse effects.
When used properly under medical supervision as a treatment for approved indications, ketamine nasal spray (intranasal ketamine) is not addictive. However, individuals with a history of substance use disorder may be at higher risk of misusing ketamine nasal spray. We do a complete medical intake covering the patient’s history before beginning treatment.
At Nushama, we implement well-studied protocols for intranasal ketamine which suggest 6 treatments over the course of 3 weeks (2x per week).
You will work with your medical provider to determine if any maintenance sessions are required beyond the initial protocol. Many patients opt to continue treatment on a weekly or bi-weekly basis following the completion of the protocol.
Ketamine nasal spray (intranasal ketamine) often starts to work within minutes of administration, with users beginning to feel its effects relatively quickly.
It is recommended not to eat at least 2 hours before your intranasal ketamine treatment to optimize its effectiveness.
No. You must have a chaperone to take you home or schedule a ride with a ride-share app like Uber or Lyft.
No. But it is required that you have a virtual medical intake with one of our medical providers before starting treatment.
Ketamine nasal spray (intranasal ketamine) can produce various sensations depending on the individual, due to factors such as dosage and personal tolerance. Here’s an idea of what intranasal ketamine might feel like:
Altered Perception:
– Ketamine is a dissociative anesthetic. Users may experience a sense of detachment from their surroundings which can lead to altered perceptions of time, space, and one’s own body.
Euphoria:
– Users may experience feelings of euphoria and an improved sense of well-being.
Changes in Body Sensation:
– Users may feel a sense of weightlessness or a disconnection from their physical body. Some report a feeling of floating or “out-of-body” experiences.
Numbness:
– Ketamine is known for its analgesic (pain-relieving) properties. Users may experience a numbing or tingling sensation.
Changes in Thought Patterns:
– Ketamine can alter thought patterns and cognitive functioning. Some users describe a feeling of “mind expansion” or a shift in their perception of reality.
Dizziness and Lack of Coordination:
– Users may experience dizziness, lack of coordination, or difficulty with motor skills.
Yes, it’s highly recommended to continue attending therapy sessions. While we’re here to support your healing, a network of mental health support often leads to the most successful outcomes.
Our 6-treatment protocol is $1,800 and our medical intake is $350 – totalling $2,150.
Each individual treatment beyond the initial protocol will be billed at $300.
Treatment includes free group integration therapy offered twice per week and an eye mask.
Ketamine nasal spray (intranasal ketamine) and Spravato (esketamine) are similar in that they are both adjunct treatments for mood disorders. However, Spravato is only FDA-approved for Treatment-Resistant Depression (TRD) and Major Depressive Disorder with Suicidal Ideation (MDSI).
If you have another diagnosis, such as Generalized Anxiety Disorder, PTSD, or any other mood disorder, you will not qualify for Spravato but you may qualify for intranasal ketamine.
Ketamine nasal spray (intranasal ketamine), at the doses administered at Nushama, is not a full psychedelic experience in the way that IV (intravenous) ketamine is. We consider it to be a gentler introduction to the psychedelic experience.
Ketamine nasal spray and intravenous (IV) infusion both deliver ketamine but differ in administration method. Nasal spray is less invasive, with a shorter duration of action, while IV infusion provides a longer-lasting effect and is considered the gold standard of ketamine therapy because of its consistency. The choice depends on individual needs and preferences.
No. Ketamine nasal spray (intranasal ketamine) must be done under professional medical supervision to ensure safety.
Individuals may not be eligible for intranasal ketamine therapy if they:
– Are pregnant
– Have uncontrolled hypertension
– Have acute cardiovascular disease
– Had a previous negative response to ketamine therapy
– Have a history of psychosis, schizophrenia , substance abuse, or increased intracranial pressure
– Active mania or unstable bipolar affective disorder
– Certain personality disorders
We do a complete medical intake covering the patient’s history before beginning treatment to ensure that they are a candidate and will not experience adverse effects.
Yes, ketamine nasal spray (intranasal ketamine) can be used alongside antidepressants. Our physicians on staff do a complete medical intake before beginning treatment to assess any current medications being taken.
Submit an inquiry to schedule a complimentary discovery call, and our team will help you find your best treatment options.
*By providing your contact information you may receive texts, e-mails and phone calls from Nushama. Reply STOP to end texts at any time. No purchase is required. Nushama currently accepts Optum (United Healthcare and Oxford) and Cigna insurance.
© 2025 NUSHAMA. ALL RIGHTS RESERVED.